All News

A two-time cancer survivor celebrates and worries about the chemicals in her life.

Patients with epithelioid sarcoma finally have a specific treatment after the FDA granted accelerated approval to Tazverik, providing new hope for the future of these patients.

In a first-of-its-kind analysis, researchers found that high body mass index may be associated with improved survival in Tecentriq-treated patients with advanced non–small cell lung cancer.

A study of the Veterans Affairs health system found that, despite trends suggesting otherwise, African American men with prostate cancer had similar survival outcomes, compared with non-Hispanic White men.

Our short animation explains how to find a clinical trial that may be right for you and shows how to apply to participate.

Facebook links my soul sister and me together. Sometimes, it's good news, but sometimes it's bad.

When Emmaly heard the words “you may have cancer,” it was the furthest thing from the mind of this 29-year-old professional.

After beating stomach cancer, a grandmother transformed herself into a competitive amateur athlete to stay active and healthy.

When all the defenses we put up have fallen you experience "crash and burn", the stage of acceptance that hurts the most but can heal you the best.

Racial and ethnic disparities have long been a part of the early detection of breast cancer in women, but a new study finds that these disparities are also connected by a patient’s insurance coverage.

This male breast cancer survivor goes back to work after a long break to consider his future and find his passion again.

Survival among patients with myelofibrosis who discontinued treatment with Jakafi appeared to have poorer survival, which was most prominent in those who stopped during the blast phase of treatment.

The American Kennel Club Donates $25,000 to Support Canine Comparative Oncology Through the V Foundation.

ESPN sports reporter Edward Aschoff died because of undetected stage 4 non-Hodgkin's lymphoma— cancer detection methods need to change.

From the FDA issuing a safety alert on cybersecurity vulnerabilities to health care facility technology to former Bachelorette star Ali Fedotowsky revealing she has basal cell carcinoma, here’s what is making headlines in the cancer space this week.

The Food and Drug Administration approved Tazverik for the treatment of patients with metastatic or locally advanced epithelioid sarcoma — marking the first treatment option specifically for these patients.

Marijuana is often linked to fighting cancer and its effects, but in the case of head and neck squamous cell carcinoma, researchers found that it may increase the progression of the disease.

Breast cancer can feel lonely and isolated, but through community, a person touched by cancer can enjoy camaraderie and support.

Save the date! We invite you to join CURE for our next monthly #CureConnect Tweet Chat on Wednesday, January 29, at 1 p.m. EST, when we plan on discussing cancer survivorship.

Some people may ask if it really matters whether it is related to cancer or not. For us it does.

A Cancer diagnosis is a life-changing event for any person, and stress is natural, so we had the chance to see how other patients with cancer have dealt with their diagnosis and its accompanying stress.

Patients with high-risk stage 3 melanoma who experienced an immune-related side effect after treatment with adjuvant Keytruda had reduced risk for disease recurrence, compared with those on the placebo arm.

With the start of a new decade, a brain cancer patient discovers what may be the most courageous way to move forward in his life.

The Food and Drug Administration granted a priority review to belantamab mafodotin for the treatment of patients with relapsed or refractory multiple myeloma.

Oncoprex in combination with Tagrisso received fast track designation from the Food and Drug Administration to treat patients with non-small cell lung cancer.

More people than ever are beginning their medical journeys online as digital videos on cancer education are proven to be a useful tool that institutions should provide.

Having someone to talk to through the cancer journey is vital, especially when that person is a fellow survivor that can understand the challenges of treatment.

One cancer survivor details how her immunotherapy changed her cancer journey for the better, and how ongoing trials of immunotherapy are looking to change the cancer landscape for the better.

Life with cancer is filled with ups and downs, but how do you deal with the roadblocks that are placed in your way? We recently asked CURE®’s social media audience how they coped with setbacks in their cancer journey. Here are some of their responses.